When was Sparrow Pharmaceuticals's last funding round?

Sparrow Pharmaceuticals's most recent recorded round was Later Stage VC (Series B) in Sep 2025, raising $95.0M.

PrivateMarketView

How much has Sparrow Pharmaceuticals raised?

$145.8Macross 4 recorded rounds · Aug 2018 – Sep 2025

Most recently, Sparrow Pharmaceuticals raised $95.0M in its Later Stage VC (Series B) (Sep 2025).

Free account

More of Sparrow Pharmaceuticals with a free account

No card required

Membership and data by Private Market View

4 rounds

Sep 2025Later Stage VC (Series B)$95.0M▮

+ 1 more investors · free account

Apr 2024Early Stage VC$10.0MSEC filing▮

4 investors participated

Dec 2020Seed Round$1.1MSEC filing▮

15 investors participated

Aug 2018Seed Round$338KSEC filing▮

10 investors participated

Sparrow Pharmaceuticals has raised $146 million across 4 recorded rounds since 2018. The largest was a $95 million Series B in Sep 2025.

Sparrow Pharmaceuticals has filed 5 Form Ds with the SEC since 2019, most recently in Jul 2025 ($61.8 million sold to 17 investors).

11 investors are on record for Sparrow Pharmaceuticals, including RA Capital Management, Keiretsu Forum, Matter (Consulting Services (B2B)) and OrbiMed. The Series B in Sep 2025 drew 4 investors.

For fundraisers

Raising for a company like Sparrow Pharmaceuticals?

11 investors have backed Sparrow Pharmaceuticals — start your target list with the firms already writing checks in drug discovery.

How much has Sparrow Pharmaceuticals raised?: Sparrow Pharmaceuticals has raised $145.8M in total across 4 recorded funding rounds.
When was Sparrow Pharmaceuticals's last funding round?: Sparrow Pharmaceuticals's most recent recorded round was Later Stage VC (Series B) in Sep 2025, raising $95.0M.